Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Urology
|
April 1, 1986
Treatment of bacterial prostatitis. Comparison of cephalexin and minocycline
D F Paulson, N R Zinner, M I Resnick, et al.
Urology
|
August 2, 2003
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence
Roger R Dmochowski, Peter K Sand, Norman R Zinner, et al.
Neurourology and Urodynamics
|
April 5, 2011
Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms
Norman R Zinner, Roger R Dmochowski, David R Staskin, et al.
The Journal of Urology
|
July 20, 2002
Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence
Roger R Dmochowski, G Willy Davila, Norman R Zinner, et al.
Neurourology and Urodynamics
|
April 12, 2002
Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies
Werner Schäfer, Paul Abrams, Limin Liao, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2015
A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors
H Henary, G C George, J Wheler, et al.
Der Urologe. Ausg. A
|
May 1, 1982
[Function of the lower urinary tract. 4th report on the standardization of terminology: neuromuscular dysfunction (author's transl)]
P Bates, W E Bradley, E Glen, et al.
Zeitschrift Fur Urologie Und Nephrologie
|
February 1, 1982
[Function of the lower urinary tract. 4th report on the standardization of terminology: neuromuscular dysfunction]
P Bates, W E Bradley, E Glen, et al.
Oncogene
|
December 22, 1999
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells
Y Lu, Y Z Lin, R LaPushin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 12, 2015
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation
S Fu, M M Hou, A Naing, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Urology
|
April 1, 1986
Treatment of bacterial prostatitis. Comparison of cephalexin and minocycline
D F Paulson, N R Zinner, M I Resnick, et al.
Urology
|
August 2, 2003
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence
Roger R Dmochowski, Peter K Sand, Norman R Zinner, et al.
Neurourology and Urodynamics
|
April 5, 2011
Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms
Norman R Zinner, Roger R Dmochowski, David R Staskin, et al.
The Journal of Urology
|
July 20, 2002
Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence
Roger R Dmochowski, G Willy Davila, Norman R Zinner, et al.
Neurourology and Urodynamics
|
April 12, 2002
Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies
Werner Schäfer, Paul Abrams, Limin Liao, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2015
A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors
H Henary, G C George, J Wheler, et al.
Der Urologe. Ausg. A
|
May 1, 1982
[Function of the lower urinary tract. 4th report on the standardization of terminology: neuromuscular dysfunction (author's transl)]
P Bates, W E Bradley, E Glen, et al.
Zeitschrift Fur Urologie Und Nephrologie
|
February 1, 1982
[Function of the lower urinary tract. 4th report on the standardization of terminology: neuromuscular dysfunction]
P Bates, W E Bradley, E Glen, et al.
Oncogene
|
December 22, 1999
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells
Y Lu, Y Z Lin, R LaPushin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 12, 2015
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation
S Fu, M M Hou, A Naing, et al.
Page
of 8